| Lastest Insider Transactions Of CRISPR Therapeutics AG ( CRSP ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2024-12-02 | Sell | 15,000 | 55.10 | 826,565 | 2024-12-04 17:35:03 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2024-11-11 | Sell | 30,000 | 55.62 | 1,668,678 | 2024-11-13 17:35:03 |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | 2024-10-13 | Sell | 1,089 | 46.28 | 50,399 | 2024-10-15 18:00:06 |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | 2024-10-13 | Option Exercise | 2,113 | 0.00 | 0 | 2024-10-15 18:00:06 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2024-10-13 | Sell | 4,293 | 46.28 | 198,680 | 2024-10-15 18:00:04 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2024-10-13 | Option Exercise | 8,333 | 0.00 | 0 | 2024-10-15 18:00:04 |
| CRSP | CRISPR Therapeutics AG | Bruno Julianne | Chief Operating Officer | 2024-06-20 | Sell | 3,366 | 56.09 | 188,799 | 2024-06-24 17:35:03 |
| CRSP | CRISPR Therapeutics AG | Bruno Julianne | Chief Operating Officer | 2024-06-20 | Option Exercise | 7,000 | 0.00 | 0 | 2024-06-24 17:35:03 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2024-04-15 | Sell | 19,582 | 59.91 | 1,173,232 | 2024-04-17 17:45:06 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2024-04-15 | Option Exercise | 19,582 | 19.12 | 374,408 | 2024-04-17 17:45:06 |
| CRSP | CRISPR Therapeutics AG | Prasad Raju | Chief Financial Officer | 2024-03-14 | Sell | 3,524 | 72.69 | 256,160 | 2024-03-18 17:45:14 |
| CRSP | CRISPR Therapeutics AG | Prasad Raju | Chief Financial Officer | 2024-03-14 | Option Exercise | 10,000 | 0.00 | 0 | 2024-03-18 17:45:14 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2024-03-15 | Option Exercise | 20,000 | 19.12 | 382,400 | 2024-03-18 17:45:09 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2024-03-15 | Sell | 20,000 | 72.48 | 1,449,628 | 2024-03-18 17:45:09 |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | 2024-03-10 | Sell | 3,947 | 77.15 | 304,515 | 2024-03-12 17:45:09 |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | 2024-03-10 | Option Exercise | 7,750 | 0.00 | 0 | 2024-03-12 17:45:09 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2024-03-10 | Sell | 14,385 | 77.04 | 1,108,263 | 2024-03-12 17:45:08 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2024-03-10 | Option Exercise | 28,250 | 0.00 | 0 | 2024-03-12 17:45:08 |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | 2024-02-18 | Sell | 1,913 | 79.67 | 152,409 | 2024-02-21 17:45:22 |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | 2024-02-18 | Option Exercise | 3,825 | 0.00 | 0 | 2024-02-21 17:45:22 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2024-02-18 | Sell | 6,370 | 79.67 | 507,498 | 2024-02-21 17:45:17 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2024-02-18 | Option Exercise | 13,250 | 0.00 | 0 | 2024-02-21 17:45:17 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2024-02-15 | Sell | 20,000 | 80.36 | 1,607,178 | 2024-02-16 17:45:12 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2024-02-15 | Option Exercise | 20,000 | 19.12 | 382,400 | 2024-02-16 17:45:12 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2024-01-29 | Sell | 50,000 | 60.51 | 3,025,573 | 2024-01-31 17:45:05 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2024-01-29 | Option Exercise | 50,000 | 19.12 | 956,000 | 2024-01-31 17:45:05 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2024-01-16 | Sell | 20,000 | 62.50 | 1,250,058 | 2024-01-18 17:45:06 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2024-01-16 | Option Exercise | 20,000 | 19.12 | 382,400 | 2024-01-18 17:45:06 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2023-05-30 | Sell | 25,000 | 64.88 | 1,621,894 | 2023-06-01 17:44:01 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2023-05-30 | Option Exercise | 25,000 | 19.12 | 478,000 | 2023-06-01 17:44:01 |
| CRSP | CRISPR Therapeutics AG | Morrow Phuong Khanh | Chief Medical Officer | 2023-05-23 | Option Exercise | 6,938 | 0.00 | 0 | 2023-05-25 17:35:47 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2023-04-25 | Sell | 25,000 | 50.67 | 1,266,638 | 2023-04-27 17:37:11 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2023-04-25 | Option Exercise | 25,000 | 19.12 | 478,000 | 2023-04-27 17:37:11 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2023-03-29 | Sell | 25,000 | 44.46 | 1,111,504 | 2023-03-31 17:49:21 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2023-03-29 | Option Exercise | 25,000 | 19.12 | 478,000 | 2023-03-31 17:49:21 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2023-03-10 | Option Exercise | 20,833 | 0.00 | 0 | 2023-03-14 17:47:12 |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | 2023-03-10 | Option Exercise | 5,083 | 0.00 | 0 | 2023-03-14 17:45:39 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2023-02-27 | Sell | 25,000 | 48.25 | 1,206,243 | 2023-03-01 18:11:03 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2023-02-27 | Option Exercise | 25,000 | 19.12 | 478,000 | 2023-03-01 18:11:03 |
| CRSP | CRISPR Therapeutics AG | Smith Brendan | Chief Financial Officer | 2023-02-18 | Option Exercise | 3,825 | 0.00 | 0 | 2023-02-22 17:41:41 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2023-02-18 | Option Exercise | 13,250 | 0.00 | 0 | 2023-02-22 17:38:54 |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | 2023-02-18 | Option Exercise | 3,825 | 0.00 | 0 | 2023-02-22 17:35:46 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2023-01-27 | Sell | 25,000 | 51.47 | 1,286,798 | 2023-01-31 17:34:35 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2023-01-27 | Option Exercise | 25,000 | 19.12 | 478,000 | 2023-01-31 17:34:35 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2022-12-28 | Sell | 25,000 | 40.93 | 1,023,290 | 2022-12-30 17:33:24 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2022-12-28 | Option Exercise | 25,000 | 19.12 | 478,000 | 2022-12-30 17:33:24 |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | 2022-12-06 | Option Exercise | 58,233 | 1.81 | 105,402 | 2022-12-08 17:35:10 |
